Monthly News Roundup – November 2020
Danyelza Gains Accelerated Approval to Treat Neuroblastoma Neuroblastoma is a solid tumor of childhood that occurs in the nervous system outside of the brain. Some tumors are easily treatable, but the majority are aggressive in nature. In November, the US Food and Drug Administration (FDA) approved Danyelza (naxitamab-gqgk) 40 mg/10 mL, used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for […]
Continue reading »